CN106237174B - A kind of anti-lung-cancer medicament and preparation method thereof suitable for obstruction of the circulation of vital energy matter - Google Patents

A kind of anti-lung-cancer medicament and preparation method thereof suitable for obstruction of the circulation of vital energy matter Download PDF

Info

Publication number
CN106237174B
CN106237174B CN201610780388.0A CN201610780388A CN106237174B CN 106237174 B CN106237174 B CN 106237174B CN 201610780388 A CN201610780388 A CN 201610780388A CN 106237174 B CN106237174 B CN 106237174B
Authority
CN
China
Prior art keywords
weight
parts
circulation
obstruction
vital energy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610780388.0A
Other languages
Chinese (zh)
Other versions
CN106237174A (en
Inventor
郑心
李士涛
张而兰
孟宪志
李佳泽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610780388.0A priority Critical patent/CN106237174B/en
Publication of CN106237174A publication Critical patent/CN106237174A/en
Application granted granted Critical
Publication of CN106237174B publication Critical patent/CN106237174B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8994Coix (Job's tears)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • A61K36/344Codonopsis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/536Prunella or Brunella (selfheal)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/748Oldenlandia or Hedyotis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/77Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/89Cyperaceae (Sedge family)
    • A61K36/8905Cyperus (flatsedge)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8966Fritillaria, e.g. checker lily or mission bells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The anti-lung-cancer medicament and preparation method thereof that the invention discloses a kind of suitable for obstruction of the circulation of vital energy matter, wherein drug includes following raw medicinal material: Radix Codonopsis, oldenlandia diffusa, Sculellaria barbata, Prunella vulgaris, edible tulip, semen litchi, raw pearl barley, bulb of thunberg fritillary, rhizoma cyperi, cortex albiziae and Radix Glycyrrhizae.The beneficial effects of the present invention are: drug of the invention is according to traditional Chinese medical theory, compatibility is reasonable, and prescription is rigorous, dissipates the stasis of blood as the rules for the treatment of using strengthening vital QI to eliminate pathogenic factors, relieve stagnation, has extraordinary anti-tumor effect of suppression cancer to obstruction of the circulation of vital energy matter lung cancer.

Description

A kind of anti-lung-cancer medicament and preparation method thereof suitable for obstruction of the circulation of vital energy matter
Technical field
The present invention relates to technical field of Chinese medicine, in particular to a kind of anti-lung-cancer medicament and its preparation suitable for obstruction of the circulation of vital energy matter Method.
Background technique
Lung cancer is one of most common malignant tumour in our times various regions, seriously threatens the health and lives of the mankind.Cancer Disease is that composite factor causes, and the constitution for neutralizing people has much relations.Middle medical circles think that the constitution of people can be divided into 9 kinds, I.e. gentle matter, deficiency of vital energy matter, deficiency of yang matter, deficiency of Yin matter, phlegm wet matter, damp and hot matter, obstruction of the circulation of vital energy matter, blood stasis matter, special official report matter.In addition to gentle matter, Other 8 kinds belong to " biased " constitution.By many years clinical summary, doctors are had found, deficiency of vital energy matter, deficiency of yang matter, deficiency of Yin matter, the obstruction of the circulation of vital energy Matter, phlegm wet matter, blood stasis matter, the people of this 6 kinds of constitutions are susceptible to suffer from tumour.Wherein, obstruction of the circulation of vital energy matter is the important body of one of many constitutions Matter is said in Huangdi's Internal Classics: " worried person, gas-tight plug and not all right ", obstruction of the circulation of vital energy constitution is mostly since long-term feelings will is unsmooth, mechanism of qi is strongly fragrant It is stagnant and formed with introverted unstable, melancholy fragile, the sensitive suspicious constitution status mainly to show.In general, it removes The reason of congenital heredity, the day after tomorrow it is long-term pressure it is excessive, and worry beyond measure and cause other than this constitution, in face of burst Direct stimulation, such as relatives are dead, suddenly frightened, also can induce to form such constitution, and after being stimulated, they Memory can also obviously decline, become amnesia.Obstruction of the circulation of vital energy constitution is mostly the thin person of body, introverted unstable, melancholy fragile, quick Feel suspicious, feel depressed, feel depressed, be easy it is nervous, anxious, it is sentimental, be easily upset, be easy to feel Fear or receive scaring, rib side of body portion or swollen breasts, gratuitous to sigh, looks are melancholy.It is said from Chinese medicine angle, human body's Qi is The basic and power of the life movement of people.The maintenance of vital movement, it is necessary to rely on gas.The gas of human body removes and native endowment, the day after tomorrow Other than environment and dietetic nutrition are related, and it is closely related with the physiological function of kidney, spleen, stomach, lung.So the various physiology of body Activity is substantially all the concrete embodiment that gas moves in human body.It ties and gathers when interior when gas cannot reach outside, just form " gas It is strongly fragrant ".Chinese medicine thinks, the obstruction of the circulation of vital energy mostly by it is melancholy it is unhappy, depressed caused by, it is unsmooth that the presence of the long-term obstruction of the circulation of vital energy often results in blood circulation, Even extravasated blood internal resistance, further results in the poor arterial inflow of entire body internal organs, and epidemiology finds the group of obstruction of the circulation of vital energy matter more It is easy to cause the generation of cancer.
Patients with lung cancer overwhelming majority when making a definite diagnosis has belonged to middle and advanced stage, is difficult to obtain satisfied treatment using single therapy method Effect.Currently, the complex treatment including traditional Chinese medicine has shown that preferable curative effect, TCM on Tumor is the spy in China Color and advantage cooperate chemotherapy etc. that can play attenuation synergistic, the good result with tumor macrobiosis by diagnosis and treatment.But at present Chinese medicine is mostly treated according to lung cancer difference parting, for example, application number 201410668907.5, it is entitled " one kind be applicable in In the lung tumor suppression cream and preparation method thereof of extreme noxious heat " patent application disclose a kind of pair of extreme noxious heat lung cancer and play suppression The drug of the effect of the anti-tumor of cancer, but foregoing invention patent application is directed to extreme noxious heat lung cancer, might not be applicable in other Type lung cancer and play good therapeutic effect.
Summary of the invention
Technical problem to be solved by the present invention lies in provide a kind of anti-lung-cancer medicament suitable for obstruction of the circulation of vital energy matter and its preparation Method, the drug dissipate the stasis of blood as the rules for the treatment of according to theory of traditional Chinese medical science, using strengthening vital QI to eliminate pathogenic factors, relieve stagnation, can obviously inhibit obstruction of the circulation of vital energy matter lung cancer tumor Growth and transfer.
In order to solve the above-mentioned technical problems, the present invention provides a kind of anti-lung-cancer medicament suitable for obstruction of the circulation of vital energy matter, the medicines Object includes following raw medicinal material: Radix Codonopsis, oldenlandia diffusa, Sculellaria barbata, Prunella vulgaris, edible tulip, semen litchi, raw pearl barley, bulb of thunberg fritillary, perfume (or spice) Attached, cortex albiziae and Radix Glycyrrhizae;Wherein, all raw medicinal materials are the medicine materical crude slice after processing;
The drug is made of the raw medicinal material of following parts by weight: Radix Codonopsis 10-20 parts by weight, oldenlandia diffusa 25-35 Parts by weight, Sculellaria barbata 25-35 parts by weight, Prunella vulgaris 20-28 parts by weight, edible tulip 20-28 parts by weight, semen litchi 20-28 weight Part, raw pearl barley 25-35 parts by weight, bulb of thunberg fritillary 13-23 parts by weight, rhizoma cyperi 7-17 parts by weight, cortex albiziae 13-23 parts by weight and Radix Glycyrrhizae 4- 14 parts by weight.
The drug is preferably made of the raw medicinal material of following parts by weight: Radix Codonopsis 12-18 parts by weight, oldenlandia diffusa 27-32 parts by weight, Sculellaria barbata 28-32 parts by weight, Prunella vulgaris 23-25 parts by weight, edible tulip 22-27 parts by weight, semen litchi 22-26 Parts by weight, raw pearl barley 27-33 parts by weight, bulb of thunberg fritillary 15-20 parts by weight, rhizoma cyperi 10-15 parts by weight, cortex albiziae 15-20 parts by weight and Radix Glycyrrhizae 6-12 parts by weight.
The drug can also preferably be made of the raw medicinal material of following parts by weight: 15 parts by weight of Radix Codonopsis, agkistrodon 30 parts by weight of tongue grass, 30 parts by weight of Sculellaria barbata, 24 parts by weight of Prunella vulgaris, 24 parts by weight of edible tulip, 24 parts by weight of semen litchi, the raw heart of a lotus seed Rice 30 parts by weight, 18 parts by weight of bulb of thunberg fritillary, 9 parts by weight of 12 parts by weight of rhizoma cyperi, 18 parts by weight of cortex albiziae and Radix Glycyrrhizae.
The drug is made of the raw medicinal material of following parts by weight again: 10 parts by weight of Radix Codonopsis, 35 weight of oldenlandia diffusa Part, 35 parts by weight of Sculellaria barbata, 20 parts by weight of Prunella vulgaris, 28 parts by weight of edible tulip, 28 parts by weight of semen litchi, 35 weight of raw pearl barley Part, 13 parts by weight of bulb of thunberg fritillary, 4 parts by weight of 7 parts by weight of rhizoma cyperi, 13 parts by weight of cortex albiziae and Radix Glycyrrhizae.
The drug can also preferably be made of the raw medicinal material of following parts by weight: 20 parts by weight of Radix Codonopsis, agkistrodon 25 parts by weight of tongue grass, 25 parts by weight of Sculellaria barbata, 28 parts by weight of Prunella vulgaris, 20 parts by weight of edible tulip, 20 parts by weight of semen litchi, the raw heart of a lotus seed Rice 25 parts by weight, 23 parts by weight of bulb of thunberg fritillary, 14 parts by weight of 17 parts by weight of rhizoma cyperi, 23 parts by weight of cortex albiziae and Radix Glycyrrhizae.
In order to preferably realize foregoing invention purpose, the present invention also provides a kind of anti-lung-cancer medicaments suitable for obstruction of the circulation of vital energy matter Preparation method, preparation method includes:
(1) all raw medicinal materials are weighed by the parts by weight, cold water is added, impregnated 2-3 hours, it is small then to boil 2-3 When, filtering obtains medical fluid one, the dregs of a decoction are spare;
(2) dregs of a decoction warm water in step (1) decocts 1-2 hours, and filtering obtains medical fluid two and the dregs of a decoction;
(3) it is filtered after merging medical fluid one and medical fluid two, continues heating and decoct, in decoction process and donkey-hide gelatin, Huang is added Wine and honey, and be stirred continuously, it decocts to the complete molten of donkey-hide gelatin, continues heating after filtering until stirring into cream taste;Wherein, Ah The additive amount of glue, yellow rice wine and honey is respectively 10-14 parts by weight, 9-11 parts by weight and 12-17 parts by weight;Preferably, donkey-hide gelatin, Huang The additive amount of wine and honey is respectively 12 parts by weight, 10 parts by weight and 15 parts by weight;
(4) cream taste is poured into while hot and carries out packing work in automatic packer, dispensed, obtained into according to every bag of 20g Product are placed on dry environment and are on the waiting list.
The beneficial effects of the present invention are: drug of the invention is according to traditional Chinese medical theory, compatibility is reasonable, and prescription is rigorous, to help It is the rules for the treatment of that positive eliminating evil, relieve stagnation, which dissipate the stasis of blood, has extraordinary anti-tumor effect of suppression cancer to obstruction of the circulation of vital energy matter lung cancer.
Specific embodiment
Tcm constitution is the important component of Basic Theories of Chinese Medicine, is a new branch of science.Phenomenon of constitution is that the mankind are raw A kind of movable important behaviour form is ordered, is referred in human vital process, in native endowment and institute's shape of acquired on the basis of At morphosis, comprehensive, metastable intrinsic speciality in terms of physiological function and psychological condition, be the mankind in growth, hair It is formed by during educating and human body personal characteristics natural, that social environment is adaptable.Constitution and card had both had the difference of essence, There are close ties again, constitution decides body to the tendency in the easy property suffered from and pathological process of certain diseases in many cases Property.The difference of constitution leads to the variability of disease: the cause of disease is identical, and constitution is different, and card is also different;Disease is identical, and constitution is different, card Also different;Disease is different, and constitution is identical, and card is also identical, i.e., constitution is with the different card of disease, different disease with the basis demonstrate,proved.
For the present invention exactly from constitution, providing for obstruction of the circulation of vital energy constitution lung cancer a kind of has effects that the medicine of tumor-inhibiting anticancer Object, including following raw medicinal material: Radix Codonopsis, oldenlandia diffusa, Sculellaria barbata, Prunella vulgaris, edible tulip, semen litchi, raw pearl barley, bulb of thunberg fritillary, Rhizoma cyperi, cortex albiziae and Radix Glycyrrhizae.Wherein, Radix Codonopsis is monarch drug in a prescription.Radix Codonopsis is sweet, flat, and returns spleen, lung two pass through, and energy tonifying spleen lung qi enriches blood, promotes the production of body fluid. " materia medica ": " tonifying spleen nourishing the stomach, moistening lung and producing body fluid are good for gas in fortune, this is not very mutually remote with ginseng ";" new compilation of materia medica ": " bowl spares benefit Gas and taste, relieving thirst and restlessness.The middle micro- void of gas is mended, very safety to adjust ".White flower oldenlandia diffusa, Sculellaria barbata, semen coicis, perfume (or spice) Attached, cortex albiziae is ministerial drug.It is white flower oldenlandia diffusa slight bitter, sweet, it trembles with fear, returns stomach, large intestine, small intestinl channel.Kind removing toxic substances heat-clearing, dampness removing are logical Leaching.Sculellaria barbata acrid flavour, slight bitter are put down, and the heart, small intestine, lung channel are entered, and have the benefits of clearing heat and detoxicating, inducing diuresis for removing edema, activating microcirculation and removing stasis medicinal.Semen coicis Sweet, light, cool, returns spleen, stomach, lung channel have the benefits of invigorating spleen for diuresis, detumescence, eliminating impediment, clearing away heat and eliminating pus.Compendium of Material Medica: " semen coicis, sun Bright medicine, can invigorating spleen and reinforcing stomach.Reinforcing the mother-organ to treat deficiency, thus consumptive lung disease, pulmonary abscess with it ".Rhizoma cyperi is pungent, slight bitter, micro- sweet and neutral.Return liver, spleen, three Jiao Jing.Can soothing liver-qi stagnation, menstruction regulating and pain relieving, in qi-regulating tune.Cortex albiziae is sweet, flat, return heart, liver, lung channel.Resolving stagnation for tranquilization, activating blood circulation and reducing swelling. Bulb of thunberg fritillary, Prunella vulgaris, edible tulip, semen litchi are adjutant.Bulb of thunberg fritillary is bitter, cold, return lung, the heart channel of Hang-Shaoyin, has clearing heat and detoxicating, dissipating bind to disappear the function of carbuncle Effect.Supplementary Amplifications of the Compendium of Materia Medica: " detoxify sharp phlegm, open the inhibited lung-energy, all lung man folder wind fire have phlegm person preferably this." Prunella vulgaris is pungent, bitter, it trembles with fear, Liver, gallbladder two is returned to pass through, clearing heat-fire, mass dissipating and swelling eliminating." Chongqing hall notes ": " Prunella vulgaris, acrid flavour and it is sweet, therefore among dissipating bind, have conjunction concurrently The function of positive yin-nourishing." edible tulip is sweet, micro-pungent, cool, and liver, spleen two is returned to pass through, clearing heat and detoxicating, dissipating bind disappears carbuncle.Semen litchi is pungent, slight bitter, temperature. Return liver, stomach meridian.Promoting the circulation of qi dissipating bind, eliminating cold to stop pain.Radix Glycyrrhizae is sweet, flat, effect tonifying middle-Jiao and Qi, expelling phlegm and arresting coughing, relieving spasm to stop pain, heat-clearing solution Poison.Raw the benefits of taking its clearing heat and detoxicating with Radix Glycyrrhizae master, and coordinating the drug actions of a prescription, to make medicine.Full side is made a general survey of, compatibility is reasonable, and prescription is rigorous, medicine Energy is special, meets traditional Chinese medical theory, all medicines share, plays strengthening vital QI to eliminate pathogenic factors altogether, relieve stagnation dissipates the stasis of blood, has the benefits of pressing down cancer anti-tumor.
The present invention will be described in detail below with reference to the drawings of preferred embodiments, whereby to the present invention how applied technology method Technical problem is solved, and the realization process for reaching technical effect can fully understand and implement.
Embodiment 1
The embodiment of the invention provides a kind of for treating the drug of obstruction of the circulation of vital energy matter lung cancer, by the bulk pharmaceutical chemicals of following parts by weight Material is made: Radix Codonopsis 150g, oldenlandia diffusa 300g, Sculellaria barbata 300g, Prunella vulgaris 240g, edible tulip 240g, semen litchi 240g, life Semen Coicis 300g, bulb of thunberg fritillary 180g, rhizoma cyperi 120g, cortex albiziae 180g and Radix Glycyrrhizae 90g;All raw medicinal materials are the medicine materical crude slice after processing;
Preparation method are as follows:
(1) all raw medicinal materials are weighed by above-mentioned weight, cold water is added, impregnated 2.5 hours, then boil 2 hours, mistake Filter, obtains medical fluid one, the dregs of a decoction are spare;
(2) dregs of a decoction warm water in step (1) decocts 1.5 hours, and filtering obtains medical fluid two and the dregs of a decoction;
(3) it is filtered after merging medical fluid one and medical fluid two, continues heating and decoct, in decoction process and donkey-hide gelatin, Huang is added Wine and honey, and be stirred continuously, it decocts to the complete molten of donkey-hide gelatin, continues heating after filtering until stirring into cream taste;Wherein, Ah The additive amount of glue, yellow rice wine and honey is respectively 120g, 100g and 150g;
(4) cream taste is poured into while hot and carries out packing work in automatic packer, dispensed, obtained into according to every bag of 20g Product are placed on dry environment and are on the waiting list.
Embodiment 2
The embodiment of the invention provides a kind of for treating the drug of obstruction of the circulation of vital energy matter lung cancer, by the raw medicinal material system of following g number At: Radix Codonopsis 100g, oldenlandia diffusa 350g, Sculellaria barbata 350g, Prunella vulgaris 200g, edible tulip 280g, semen litchi 280g, raw pearl barley 350g, bulb of thunberg fritillary 130g, rhizoma cyperi 70g, cortex albiziae 130g and Radix Glycyrrhizae 40g;All raw medicinal materials are the medicine materical crude slice after processing;
Preparation method are as follows:
(1) all raw medicinal materials are weighed by above-mentioned weight, cold water are added, impregnated 3 hours, then boil 2 hours, filtered, Medical fluid one is obtained, the dregs of a decoction are spare;
(2) dregs of a decoction warm water in step (1) decocts 1 hour, and filtering obtains medical fluid two and the dregs of a decoction;
(3) it is filtered after merging medical fluid one and medical fluid two, continues heating and decoct, in decoction process and donkey-hide gelatin, Huang is added Wine and honey, and be stirred continuously, it decocts to the complete molten of donkey-hide gelatin, continues heating after filtering until stirring into cream taste;Wherein, Ah The additive amount of glue, yellow rice wine and honey is respectively 100g, 90g and 170g;
(4) cream taste is poured into while hot and carries out packing work in automatic packer, dispensed, obtained into according to every bag of 20g Product are placed on dry environment and are on the waiting list.
Embodiment 3
The embodiment of the invention provides a kind of for treating the drug of obstruction of the circulation of vital energy matter lung cancer, by the raw medicinal material system of following g number At: Radix Codonopsis 200g, oldenlandia diffusa 250g, Sculellaria barbata 250g, Prunella vulgaris 280g, edible tulip 200g, semen litchi 200g, raw pearl barley 250g, bulb of thunberg fritillary 230g, rhizoma cyperi 170g, cortex albiziae 230g and Radix Glycyrrhizae 140g;All raw medicinal materials are the medicine materical crude slice after processing;
Preparation method are as follows:
(1) all raw medicinal materials are weighed by above-mentioned weight, cold water are added, impregnated 2 hours, then boil 3 hours, filtered, Medical fluid one is obtained, the dregs of a decoction are spare;
(2) dregs of a decoction warm water in step (1) decocts 2 hours, and filtering obtains medical fluid two and the dregs of a decoction;
(3) it is filtered after merging medical fluid one and medical fluid two, continues heating and decoct, in decoction process and donkey-hide gelatin, Huang is added Wine and honey, and be stirred continuously, it decocts to the complete molten of donkey-hide gelatin, continues heating after filtering until stirring into cream taste;Wherein, Ah The additive amount of glue, yellow rice wine and honey is respectively 140g, 110g and 120g;
(4) cream taste is poured into while hot and carries out packing work in automatic packer, dispensed, obtained into according to every bag of 20g Product are placed on dry environment and are on the waiting list.
Syndrome is the core and soul of Chinese medicine, and zoopery is to connect basic medical and clinical bridge and tie, Therefore carry out with disease combination principle be instruct zoopery be TCM basis research the only way which must be passed.But due to animal and Otherness (such as language expression symptom, tongue picture, pulse condition, the colour of skin and feelings will symptom) between human body, determines that tcm syndrome exists It is simulated with animal larger with the difficulty of judgement.Therefore, have using TCM syndrome diagnostic criteria to be distinctive with guiding principle, with animal The information characteristics of diagnostic significance carry out integration comparison, equivalent association, and accurate, quantization modern physiological pathological biochemistry is combined to refer to Mark is to evaluate Chinese medicine to the effective way of Animal diseases and therapeutic effect of syndrome.Therefore, the present invention is carried out following right by animal model Than test, for proving that drug of the invention has a clear superiority in treatment obstruction of the circulation of vital energy matter lung cancer.
Comparative test
Main agents and drug are as follows:
Interferon-γ (IFN-γ) enzyme-linked immunoassay kit: Bioengineering Research Institute is built up in Nanjing;Leucocyte is situated between Element -2(IL-2) enzyme-linked immunoassay kit: Nanjing is built up in Bioengineering Research Institute;Southern Sea Brand cigarette: BJ Tobacco Factory is raw It produces, tar content 8mg, nicotine content in smoke: 0.8mg, carbon monoxide in flue gas content: 10mg;Hydrocortisone injection is purchased from day Saliva medicine company Jiaozhuo Co., Ltd;Adrenalin hydrochloride injection, specification 1g:1mg are purchased from Shanghai Hefeng Pharmaceutical Co., Ltd.;It is small Mouse thyroid-stimulating hormone (TSH) enzyme-linked immunoassay kit;Corticotropin (ACTH) enzyme-linked assay kit, by south Bioengineering Research Institute's offer is built up in capital;Testosterone (T) radioimmunoassay kitss, by Tianjin Jiuding Medical Biological Engineering Co., Ltd It provides;Cyclic adenosine monophosphate (cAMP) enzyme-linked immunoassay kit: Bioengineering Research Institute is built up in Nanjing;Follicle-stimulating hormone (FSH) Enzyme-linked immunoassay kit: Bioengineering Research Institute is built up in Nanjing;High lipid food is purchased from Shandong Province's disease control and prevention The heart;Interleukins radio-immunity test kit (IL-6), builds up Bioengineering Research Institute purchased from Nanjing;Vascular endothelial growth Factor C(VEgF-C) enzyme-linked immunoassay kit: Bioengineering Research Institute is built up in Nanjing;DAB color developing agent: it is purchased from China fir in Beijing Biotechnology Co., Ltd, Golden Bridge;OVA (grade), AI (OH) 3 are purchased from Sigma, USA;0.9% sodium chloride injection, is purchased from The tomb Guo great pharmaceutical Co. Ltd.
Experiment equipment is as follows:
Superclean bench: Beijing Great Wall air purification engineering company
Animal contaminated case: Shanghai Yu Yan scientific instrument Co., Ltd
High-pressure sterilizing pot: Japanese Sanyo company
Microplate reader: Thermo company, the U.S.
Inverted microscope: Japanese Olympus company
Disecting microscope: Japanese Nikon company
CO2 cell incubator: German Teraeus company
Vernier caliper: Shanghai experimental measurement company
Superspeed refrigerated centrifuge: German Herge company
Analytical precision balances: Mettler company, Switzerland
- 80 DEG C of refrigerators: Japanese Sanyo company
General refrigerator: Qingdao HaiEr Co., Ltd
Cell counting board: Shanghai precision instrumentation Co., Ltd
Micropipettor: German Eppendor company
Automatic blood rheology test instrument is provided by Center for Disease Control, Shandong Province.
One, gentle constitution and obstruction of the circulation of vital energy constitution model are established
1 experimental animal
Animal strains C57BL/6 inbred strais black rat, grade SPF rank, male, 6-8 week old, weight 18 ± 2g, 80, Quality testing unit: Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences sells unit: Beijing China Fukang biotechnology share Co., Ltd, credit number: SCXK (capital) 2009-0004.
2 test methods
2.1 feeding method
It feeds in SPF grades of animal houses (Center for Disease Control, Shandong Province animal house), room temperature (22 ± 2) DEG C, humidity (55 ± 5) %, each 12h of artificial lighting light and shade, well-ventilated;Mouse maintains feed, pulls together feed corporation,Ltd purchased from Beijing Austria, section, license Card number: the capital SCXK() 2009-0012;Free water;Padding is replaced in time according to padding situation.
2.2 groupings and modeling method
2.2.1 group technology:
80 Lewis mouse are randomly divided into two experimental groups, each experimental group 40, respectively gentle matter group and the obstruction of the circulation of vital energy Matter group.
2.2.2 modeling method:
Two groups of mouse are raised respectively two weeks with different rearing conditions, the rearing conditions of two experimental groups are specific as follows:
(1) it gentle matter group: feeds with normal diet, free water, room temperature (22 ± 2) DEG C, humidity (55 ± 5) %, artificial light Illuminate dark each 12h.It is continuous to feed 14 days under the conditions of well-ventilated.
(2) obstruction of the circulation of vital energy matter group: feeding 7 days under the conditions of above-mentioned gentle matter group, then from the 8th day to the 14th day, is tied up with band Firmly rat four limbs, and continue to feed using the feed mode of gentle matter group.
3 experimental evaluation indexs and result
The observation of 3.1 mouse weights
Each test group of animals respectively surveys a weight after before experiment starts with experiment.The measured body weight time is 9: 00am-10:00am calculates the average weight of two experimental mice experiment front and backs, and the results are shown in Table 1.
1 liang of experimental mice experiment forward backward averaging weight of table () table of comparisons
By above-mentioned data it is found that obstruction of the circulation of vital energy matter group is compared with gentle matter group mouse weight, the T inspection through two independent samples It tests, P < 0.05 is statistically analyzed, and each group of data weight has differences, and has statistical significance.Wherein, obstruction of the circulation of vital energy matter group is small Mouse average weight is significantly less than gentle matter group average mice body weight.
The observation of 3.2 mouse macroscopic tokens
Life habit, the state of mind, food-intake, the hair situation, size of two experimental mices are observed and recorded daily Just situations such as situation, skin and train of thought color, extravasated blood change.It is as follows to observe result:
(1) gentle matter group: mouse shows as active active, is quick on the draw, back hair color is glossy, and feed water is normal;
(2) obstruction of the circulation of vital energy matter group: mouse gradually appears the performance of obstruction of the circulation of vital energy constitution, and such as burnout lazy move, apathetic, four limbs are crispaturaed, Being irritable and getting angry easily, emotional, food-intake is reduced.
3.3 Evaluation of blood test and method
In experiment the 15th day, 5 mouse are respectively randomly selected from two groups of mouse, blood are taken using eye socket blood extracting method, after taking blood It is added in the test tube without anti-coagulants, room temperature blood natural coagulation 10-20 minutes, is centrifuged 25 minutes (2500 revs/min).Carefully collect Upper serum should be centrifuged again as precipitated during preservation.Serum is subjected to following Indexs measure respectively:
(1) ACTH content in serum: ACTH is detected using enzyme-linked immunosorbent assay instrument (microplate reader).The results are shown in Table 2.
The ACTH content table of comparisons in 2 two groups of mice serums of table (± S)
Group ACTH(pg/g)
Gentle matter group 31.51±10.12*
Obstruction of the circulation of vital energy matter group 58.67±6.81
It is independent through two by above-mentioned data it is found that obstruction of the circulation of vital energy matter group is compared with ACTH content in gentle matter group mice serum The T of sample is examined, and P < 0.05 is statistically analyzed, having differences property of each group of data, and obstruction of the circulation of vital energy matter group mouse ACTH content is obvious Higher than gentle matter group mouse ACTH content.
(2) it whole blood viscosity: is carried out respectively with tri- shear rates of 10S-1,50S-1,200S-1 with lectin from hemolymph automatic tester Whole blood viscosity detection.The results are shown in Table 3.
3 two groups of mice serum whole blood viscosity tables of comparisons of table (± SmPaS)
Group 10S-1(mPaS) 50S-1(mPaS) 200S-1(mPaS)
Gentle matter group 11.31±1.03 5.49±1.19 3.88±0.62
Obstruction of the circulation of vital energy matter group 13.82±1.21* 8.12±1.11** 6.41±0.83***
Note: * P < 0.05;* P < 0.05;* * P < 0.05.
By above-mentioned data it is found that obstruction of the circulation of vital energy matter group is compared with gentle matter group Mouse whole blood viscosity, the T through two independent samples It examines, P < 0.05, each group of data has differences, and has statistical significance, the whole blood under obstruction of the circulation of vital energy matter group three groups of shear rates of mouse Viscosity is obviously higher than gentle matter group Mouse whole blood viscosity.
To sum up, by the observation of table 1, the data of table 2 and table 3 and macroscopic token it is found that two groups of mouse are in weight and characterization There is notable difference, there is also significant differences for ACTH content and whole blood viscosity in serum, and obstruction of the circulation of vital energy matter group mouse from characterization and is surveyed Fixed number illustrates that this constitution modeling experiment is stablized effectively, models successfully according to matching with obstruction of the circulation of vital energy constitutive character.
Two, the lung cancer model of gentle constitution and obstruction of the circulation of vital energy constitution is established
1 experimental animal and cell strain
Experimental animal of two experimental mices (every group 40) as this modeling after the modeling of above-mentioned constitution, and respectively As gentle matter group and obstruction of the circulation of vital energy matter group.
Lewis lung cancer cell line, is provided by Shandong Academy of Medical Sciences and is inoculated with, and is inoculated with random from mouse kind with mouse Extract 5 progress lotus knurls.It is sent to laboratory after being inoculated with successfully and carries out conventinal breeding.
2 experimental methods and step
2.1 tumor cell inoculations for the first time
It takes the tumour of the C57BL/6 mouse of lotus Lewis lung carcinoma cell as knurl source, mouse cervical dislocation is put to death, ultra-clean work Make to separate tumor tissues of the well-grown pale pink without necrosis under platform aseptic condition.It is cut into small pieces with tissue shear, by tumor (g): The ratio of physiological saline (g) 1:3 is unidirectionally ground into homogenate with glass homogenizer, crosses 200 mesh nylon wires, at single cell suspension, receives It combines in centrifuge tube.With superspeed refrigerated centrifuge, 1000r/min is centrifuged 3min, abandons supernatant, and physiological saline is added, and is centrifuged with method It washed once.Tumor cell suspension is taken, 0.4% trypan blue dye liquor is added, trypan blue exclusion experiment shows that living cells is greater than 95%, adjustment Cell concentration is 1.0*107/g。
Aseptically, with syringe inoculated tumour cell suspension 0.2g/ at the armpit of two experimental mices (a containing about oncocyte 2.0*106) mixes suspension before being inoculated with every time, cell infusion is slightly suitable after the completion to press pin hole, prevents liquid It overflows.
The 5th day after inoculation, two test group mouse-borne tumor success or not are observed, lotus knurl success mouse is that lung cancer is modeled as Function.
Three, drug study
The successful mouse of lotus knurl 30 in above-mentioned two groups is chosen respectively, as the animal model of drug study, and by every group 30 mouse are randomly divided into Liang Ge group, and respectively gentle matter control group, gentle matter are to drug, obstruction of the circulation of vital energy matter control group and obstruction of the circulation of vital energy matter Administration group, 15 mouse of each group.Specific medication is as shown in table 4:
Table 4 respectively tests the medication of group mouse
Note: above-mentioned dosage is equivalent to 70kg adult by the equivalent dose of body surface area conversion dosage, is equivalent to simultaneously 10 times of per weight people's dosage.
Composition analyzed index and result:
(1) weight: after above-mentioned administration mode continuous use four weeks, claim each group mouse weight with electronic balance and remember The results are shown in Table 5 for record;
Table 5 respectively tests group's average mice body weight table of comparisons after being administered
Group Quantity (only) Average weight (g)
Gentle matter control group 15 27.06±2.10
Gentle matter administration group 15 32.37±1.62
Obstruction of the circulation of vital energy matter control group 15 25.03±2.81
Obstruction of the circulation of vital energy matter administration group 15 27.35±2.73
From the above data, it can be seen that one-way analysis of variance, big group difference shows: P < 0.05, has significant difference Property;Further progress compares two-by-two, and the administration group of every kind of constitution grouping is compared with non-medication group, and: P < 0.05 has significant difference Property;One-way analysis of variance: P > 0.05 is carried out between different constitution administration groups, does not have otherness.
(2) gross tumor volume: the 7th day after inoculation, 10 days, 13 days, 16 days, 19 days, 22 days, 25 days, 28 days, precision is used For 0.1mm vernier caliper measurement and record mouse subcutaneous tumors tubercle size, calculate gross tumor volume, calculation formula: V (cm3)= 0.52×ab2(a is knurl longest diameter, and b is shortest diameter).The average value of every group's mouse tumor volume is calculated, as a result such as table 6 It is shown.
Each group's mouse tumor average external volume change situation (cm3) during being administered of table 6
It is swollen according to the mouse of group to can be seen that gentle matter control group, gentle matter administration group and obstruction of the circulation of vital energy confrontation by above-mentioned data Knurl product growth rate is essentially identical, and under drug effect, administration group volume growth rate gradually slows down since the mid-term, rather than Administration group, tumour growth rate have the tendency that speeding earlier above.Every kind of constitution administration group and non-medication group carry out statistical procedures, P < 0.05.
(3) knurl weight and tumour inhibiting rate: each group mouse is put to death in dislocation of craning one after 28 days after inoculation, removes mouse skin rapidly Lower tumour claims knurl weight, calculates each group tumor control rate, the results are shown in Table 7.
Wherein, the calculation formula of tumor control rate are as follows:
Tumor control rate=(the gentle average knurl weight of matter control group average knurl weight-to be measured group)/gentle matter control group is averaged tumor Weight × 100%.
Each experiment group mouse knurl final weight table of comparisons of table 7 (± S, g)
Group Quantity (only) Knurl weight (g) Tumour inhibiting rate (%)
Gentle matter control group 15 7.86±1.27 0
Gentle matter administration group 15 5.91±1.43 24.81
Obstruction of the circulation of vital energy matter control group 15 9.72±0.47 -23.66
Obstruction of the circulation of vital energy matter administration group 15 5.59±0.74 28.88
It can be seen that every kind of constitution Liang Ge group by above-mentioned data to compare through row: gentle matter administration group and gentle confrontation Comparing: P < 0.05 according to group has extremely significant otherness;Obstruction of the circulation of vital energy matter administration group is compared with obstruction of the circulation of vital energy matter control group, and: P < 0.05 has Significance difference is anisotropic.Various difference constitution administration groups compare P > 0.05, no significant difference.Illustrate drug of the invention to mouse tumor Growth have apparent inhibiting effect, and two kinds of constitution model mice tumor inhibitory effects are showed well, two kinds of constitutions are small Mouse tumour inhibiting rate no significant difference.
(4) after mouse is put to death, two sides lungs Lung metastases inhibiting rate: are separated.It is fixed for 24 hours with 4% paraformaldehyde solution.In Pulmonary metastases stove is counted under disecting microscope, transfer stove is the protuberance of white or milky nodal-like.This test is using counting It is completed under double-blind conditions, the results are shown in Table 8.
Wherein, the calculation formula of Lung metastases inhibiting rate are as follows:
Lung metastases inhibiting rate (%)=(gentle matter control group be averaged lung surface metastatic nodules-to be measured group respectively be averaged lung table Face metastatic nodules)/gentle matter control group is averaged Lung metastases tubercle number × 100%.
Table 8 respectively experiment group mouse Pulmonary metastasis focuses number and Lung metastases inhibiting rate (± S)
Group Quantity (only) Pulmonary metastasis focuses number (a) Lung metastases inhibiting rate (%)
Gentle matter control group 15 11.30±2.95 0
Gentle matter administration group 15 8.35±1.78 26.10
Obstruction of the circulation of vital energy matter control group 15 11.10±1.20 1.77
Obstruction of the circulation of vital energy matter administration group 15 7.70±2.36 31.85
It can be seen that every kind of constitution Liang Ge group by above-mentioned data to be compared: gentle matter administration group and gentle confrontation Comparing: P < 0.05 according to group has extremely significant otherness;Obstruction of the circulation of vital energy matter administration group is compared with obstruction of the circulation of vital energy matter control group, and: P < 0.05 has Significant difference;Various difference constitution administration groups compare P > 0.05, no significant difference.Illustrate that drug of the invention can reduce mouse Neoplasm lung metastasis rate, and it is directed to above two constitution no significant difference.
(5) the VEGF immunohistochemistry detection of tumor tissues
Sample is made in the tumor tissues that each experiment group randomly selects 10 mouse, and is respectively put into 10% neutral good fortune Fixed in your Malin's solution 4 μM of serial section 2 of row are opened for 24 hours, row VEGF dyeing, microwave antigen retrieval, conventional dehydration, transparent, leaching Wax, embedding.According to the operation for illustrating to carry out immunohistochemistry of SABC method staining kit.
It is expressed using immunohistochemical method SP method count detection VEGF-C, all samples are normal after fixation, embedding, slice Advise row HE dyeing.Primary antibody is rabbit-anti mouse monoclonal antibody, and 1:100 dilution, biotinylation secondary antibody is goat anti-mouse Igg.Each reality It is as shown in table 9 to test group's VEGF ImmunohistochemistryResults Results.
Table 9 respectively the positive cell VEGE-C average optical density table of comparisons in experiment group's tumor tissues (± S)
Group Quantity (only) Average optical density
Gentle matter control group 10 0.158±0.033
Gentle matter administration group 10 0.131±0.040
Obstruction of the circulation of vital energy matter control group 10 0.197±0.034
Obstruction of the circulation of vital energy matter administration group 10 0.154±0.023
It can be seen that every kind of constitution Liang Ge group by above-mentioned data to be compared: gentle matter administration group and gentle confrontation Comparing: P < 0.05 according to group has extremely significant otherness;Obstruction of the circulation of vital energy matter administration group is compared with obstruction of the circulation of vital energy matter control group, and: P < 0.05 has Significance difference is anisotropic.Comparison among groups: P > 0.05, no significant difference are administered in two kinds of different constitutions.Illustrate that drug of the present invention can reduce Vegf expression reduces Tumor Angiongesis, and then inhibits tumour growth.
(6) serum Testing index (ACTH and whole blood viscosity)
Before putting to death after the end of the experiment, under a clean environment respectively to obstruction of the circulation of vital energy matter control group and obstruction of the circulation of vital energy matter administration group Mouse eyeground takes blood, and blood sample is placed in anticoagulation test tube.With the content of ACTH in enzyme-linked immunization measurement peripheral blood serum And whole blood viscosity, as a result as shown in Table 10 and Table 11.
ACTH content in 10 liang of experiment group mice serums of table (± S, pg/g)
Group ACTH(pg/g)
Obstruction of the circulation of vital energy matter control group 59.93±6.29
Obstruction of the circulation of vital energy matter administration group 34.58±8.32*
11 liang of experiment group Mouse whole blood viscosity measurements of table (±S ,mPa·S)
Group Quantity (only) 10S-1 50S-1 200S-1
Obstruction of the circulation of vital energy matter control group 15 16.82±1.21 11.18±1.11 8.41±0.83
Obstruction of the circulation of vital energy matter administration group 15 12.74±0.56 7.82±1.21 4.21±1.21
By above-mentioned data it is found that ACTH content is significantly lower than obstruction of the circulation of vital energy matter control group in the mice serum of obstruction of the circulation of vital energy matter administration group, And closer to the ACTH content value of normal mouse.Illustrate that drug of the invention has the effect for adjusting corticotropin Fruit, and then by adjusting biased constitution, play the role of anticancer.
To sum up, pass through above-mentioned animal model test, it can be seen that drug of the invention can be improved the body of obstruction of the circulation of vital energy matter mouse Weight, while having the effect of reducing tumour growth rate and reducing mouse tumor Lung metastases rate, and can reduce vegf expression and subtract Few Tumor Angiongesis, adjusts the effect of corticotropin, to adjust biased constitution, and then enhances tumor-inhibiting anticancer Effect, the i.e. present invention can have the effect of extraordinary tumor-inhibiting anticancer to obstruction of the circulation of vital energy matter lung cancer population.
The foregoing is merely presently preferred embodiments of the present invention, is not intended to limit the invention, it is all in spirit of the invention and Within principle, any modification, equivalent replacement, improvement and so on be should all be included in the protection scope of the present invention.

Claims (5)

1. a kind of anti-lung-cancer medicament suitable for obstruction of the circulation of vital energy matter, which is characterized in that the drug by following parts by weight bulk pharmaceutical chemicals Material is made: Radix Codonopsis 10-20 parts by weight, oldenlandia diffusa 25-35 parts by weight, Sculellaria barbata 25-35 parts by weight, Prunella vulgaris 20-28 weight Measure part, edible tulip 20-28 parts by weight, semen litchi 20-28 parts by weight, raw pearl barley 25-35 parts by weight, bulb of thunberg fritillary 13-23 parts by weight, perfume (or spice) Attached 7-17 parts by weight, cortex albiziae 13-23 parts by weight and Radix Glycyrrhizae 4-14 parts by weight.
2. the anti-lung-cancer medicament according to claim 1 suitable for obstruction of the circulation of vital energy matter, which is characterized in that the drug is by following heavy Amount number raw medicinal material be made: Radix Codonopsis 12-18 parts by weight, oldenlandia diffusa 27-32 parts by weight, Sculellaria barbata 28-32 parts by weight, Prunella vulgaris 23-25 parts by weight, edible tulip 22-27 parts by weight, semen litchi 22-26 parts by weight, raw pearl barley 27-33 parts by weight, bulb of thunberg fritillary 15-20 parts by weight, rhizoma cyperi 10-15 parts by weight, cortex albiziae 15-20 parts by weight and Radix Glycyrrhizae 6-12 parts by weight.
3. the anti-lung-cancer medicament according to claim 1 suitable for obstruction of the circulation of vital energy matter, which is characterized in that the drug is by following heavy The raw medicinal material of amount number is made: 15 parts by weight of Radix Codonopsis, 30 parts by weight of oldenlandia diffusa, 30 parts by weight of Sculellaria barbata, Prunella vulgaris 24 Parts by weight, 24 parts by weight of edible tulip, 24 parts by weight of semen litchi, 30 parts by weight of raw pearl barley, 18 parts by weight of bulb of thunberg fritillary, 12 weight of rhizoma cyperi Part, 9 parts by weight of 18 parts by weight of cortex albiziae and Radix Glycyrrhizae.
4. the anti-lung-cancer medicament according to claim 1-3 suitable for obstruction of the circulation of vital energy matter, which is characterized in that the drug Preparation method the following steps are included:
(1) all raw medicinal materials are weighed by the parts by weight, cold water is added, impregnated 2-3 hours, then boil 2-3 hours, mistake Filter, obtains medical fluid one, the dregs of a decoction are spare;
(2) dregs of a decoction warm water in step (1) decocts 1-2 hours, and filtering obtains medical fluid two;
(3) will medical fluid one and medical fluid two merge after filter, continue heating and decoct, in decoction process and be added donkey-hide gelatin, yellow rice wine and Honey, and be stirred continuously, it decocts to the complete molten of donkey-hide gelatin, continues heating after filtering until stirring into cream taste;Wherein, donkey-hide gelatin, Huang The additive amount of wine and honey is respectively 10-14 parts by weight, 9-11 parts by weight and 12-17 parts by weight;
(4) cream taste is poured into while hot and carries out packing work in automatic packer, dispensed according to every bag of 20g, obtain finished product, put It sets and is on the waiting list in dry environment.
5. the preparation method of the anti-lung-cancer medicament according to claim 1-3 suitable for obstruction of the circulation of vital energy matter, feature exist In the preparation method comprises the following steps:
(1) all raw medicinal materials are weighed by the parts by weight, cold water is added, impregnated 2-3 hours, then boil 2-3 hours, mistake Filter, obtains medical fluid one, the dregs of a decoction are spare;
(2) dregs of a decoction warm water in step (1) decocts 1-2 hours, and filtering obtains medical fluid two;
(3) will medical fluid one and medical fluid two merge after filter, continue heating and decoct, in decoction process and be added donkey-hide gelatin, yellow rice wine and Honey, and be stirred continuously, it decocts to the complete molten of donkey-hide gelatin, continues heating after filtering until stirring into cream taste;Wherein, donkey-hide gelatin, Huang The additive amount of wine and honey is respectively 10-14 parts by weight, 9-11 parts by weight and 12-17 parts by weight;
(4) cream taste is poured into while hot and carries out packing work in automatic packer, dispensed according to every bag of 20g, obtain finished product, put It sets and is on the waiting list in dry environment.
CN201610780388.0A 2016-08-31 2016-08-31 A kind of anti-lung-cancer medicament and preparation method thereof suitable for obstruction of the circulation of vital energy matter Active CN106237174B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610780388.0A CN106237174B (en) 2016-08-31 2016-08-31 A kind of anti-lung-cancer medicament and preparation method thereof suitable for obstruction of the circulation of vital energy matter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610780388.0A CN106237174B (en) 2016-08-31 2016-08-31 A kind of anti-lung-cancer medicament and preparation method thereof suitable for obstruction of the circulation of vital energy matter

Publications (2)

Publication Number Publication Date
CN106237174A CN106237174A (en) 2016-12-21
CN106237174B true CN106237174B (en) 2019-05-10

Family

ID=58080082

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610780388.0A Active CN106237174B (en) 2016-08-31 2016-08-31 A kind of anti-lung-cancer medicament and preparation method thereof suitable for obstruction of the circulation of vital energy matter

Country Status (1)

Country Link
CN (1) CN106237174B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103768523A (en) * 2014-01-10 2014-05-07 殷东风 Chinese herbal medicine compound preparation for treating malignant tumors and preparation method of compound preparation
CN104324331A (en) * 2014-11-20 2015-02-04 郑心 Lung tumor suppression cream applied to Qi-stagnation and blood stasis and preparation method of lung tumor suppression cream
CN104352797A (en) * 2014-12-04 2015-02-18 崔合芳 Traditional Chinese medicine for treating advanced lung cancer and application of traditional Chinese medicine
CN104547525A (en) * 2014-12-31 2015-04-29 青岛市市立医院 Drug composition for NSCLC (Non Small Cell Lung Cancer) prevention and preparation method thereof

Also Published As

Publication number Publication date
CN106237174A (en) 2016-12-21

Similar Documents

Publication Publication Date Title
CN100525824C (en) Chinese-medicinal composition for treating chronic gastritis and atrophic gastritis and its production
CN106421633A (en) Pharmaceutical composition for treating Hashimoto&#39;s thyroiditis and preparation method thereof
CN102688321A (en) Traditional Chinese medicine preparation improving health of nursing sows and piglets thereof by maternal therapy
CN102240318A (en) Traditional Chinese medicine for tonifying qi and increasing breast milk
CN105327069A (en) Formulation, preparation method and application of liver soothing traditional Chinese herbal medicine composition
CN104147180B (en) Pharmaceutical composition for the treatment of immunologic thrombocytopenic purpura and preparation method thereof
CN106237174B (en) A kind of anti-lung-cancer medicament and preparation method thereof suitable for obstruction of the circulation of vital energy matter
CN102652774B (en) Drug composition for treating leukopenia and hypoimmunity caused by chemoradiotherapy and preparation method and quality detection method
CN104524292A (en) Application of traditional Chinese medicine preparation in preparation of medicament for treating obesity
CN106177054A (en) A kind of Hyperglycemic health care compositions comprising Cortex Mori and Pericarpium Citri Reticulatae
CN104623314A (en) Medicine composition for treating dry mouth and bitter taste and preparation method thereof
CN103191399A (en) Traditional Chinese medicine composition for treating bronchial asthma in acute-outbreak period
CN106266765B (en) A kind of anti-lung-cancer medicament and preparation method thereof suitable for phlegm wet matter
CN101190306A (en) Compound composition with qi-complementing and spleen-invigorating function and preparation method and application thereof
CN103285173A (en) Traditional Chinese medicine for treating thrombocytopenic purpura
CN109663100B (en) Traditional Chinese medicine composition for treating optic neuritis and preparation method and application thereof
CN101658567A (en) Medicament for treating coronary heart disease and angina and preparation method of granular formulation thereof
CN104547738A (en) Traditional Chinese medicine preparation for treating obesity and preparation method of traditional Chinese medicine preparation
CN104383449B (en) Pharmaceutical composition for treating depression syndrome
CN103721066B (en) A kind of decoction for the treatment of tumor
CN103239665B (en) Traditional Chinese medicine composition for treating sepsis
CN102743577A (en) Traditional Chinese medicine composite for promoting expression of aquaporin-5 (AQP5) and preparation method and application of traditional Chinese medicine composite
CN103877509B (en) A kind of medicine and its preparation method treating leukemia
CN118001323B (en) Traditional Chinese medicine composition for preventing and treating anxiety disorder and preparation method and application thereof
CN107596109A (en) A kind of Chinese medicine preparation for treating idiopathic pulmonary fibrosis paracmasis disease and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP02 Change in the address of a patent holder

Address after: No.2 Huanxi Road, diaopu street, Gaogang District, Taizhou City, Jiangsu Province 225300

Patentee after: Zheng Xin

Address before: 250001 the Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, No. eight 1, Shandong, Ji'nan, China

Patentee before: Zheng Xin

CP02 Change in the address of a patent holder
CP02 Change in the address of a patent holder

Address after: The Second Affiliated Hospital of Shandong University of traditional Chinese medicine, No.1 Jingba Road, Jinan City, Shandong Province

Patentee after: Zheng Xin

Address before: 225300 No.2 Huanxi Road, diaopu street, Gaogang District, Taizhou City, Jiangsu Province

Patentee before: Zheng Xin

CP02 Change in the address of a patent holder